Tecan Group AG (TECN.SW)

CHF 202.6

(-2.03%)

Market Cap (In CHF)

2.59 Billion

Revenue (In CHF)

1.07 Billion

Net Income (In CHF)

132.07 Million

Avg. Volume

34.91 Thousand

Currency
CHF
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
201.4-392.0
PE
-
EPS
-
Beta Value
0.702
ISIN
CH0012100191
CUSIP
-
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Medical - Instruments & Supplies
CEO
Dr. Achim von Leoprechting Ph.D.
Employee Count
-
Website
https://www.tecan.com
Ipo Date
1995-04-10
Details
Tecan Group AG provides laboratory instruments and solutions for pharmaceutical and biotechnology companies, university research departments, and forensic and diagnostic laboratories. It operates through Life Sciences Business and Partnering Business segments. The company offers liquid handling and automation, microplate readers and washers, consumables, NGS reagents, immunoassays and microbodies, and software; Tecan Laberwax, an automation solution; Resolvex, a smart sample preparation solution for use in genomics, synthetic biology, drug discovery, analytical chemistry, cell biology, protein science, applied markets, and ELISA solutions. It also develops and manufactures laboratory instrument manufacturers with essential components comprising precision pumps, valves, robotic arms, and developer software for life science research, diagnostics, and various other industries; Synergence, platform-based automation solution; and Freedom EVO and Fluent instruments. The company operates in Switzerland and Other European countries, North America, Asia, and internationally. Tecan Group AG was founded in 1980 and is headquartered in Männedorf, Switzerland.

More Stocks